Selectable fusion protein having aminoglycoside phosphotransfera

Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Transferase other than ribonuclease

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435232, 435190, 4351723, 435 697, 530350, C12N 910, C12N 904, C12N 1500

Patent

active

051167506

ABSTRACT:
A novel a selectable fusion protein having aminoglycoside phosphotransferase activity is disclosed. The marker comprises the coding sequences for aminoglycoside phosphotransferase I (APH-I) which has been modified and truncated so as to render its use in recombinant vectors more convenient. The modified, truncated sequence (mtAPH-I) gene is capable, upon expression, of conferring resistance to a number of antibiotics on the host. One of these antibiotics, G418, is toxic to eucaryotic as well as procaryotic hosts. Also disclosed are methods of constructing fusion proteins having N-terminal sequences corresponding to a desired peptide sequence, and C-terminal sequences comprising the amino acids encoded by mtAPH-I. The preferred N-terminal sequences are the first 11 amino acids of .beta.-isopropyl malate dehydrogenase, and the first 7 amino acids of yeast enolase.

REFERENCES:
Southern, P. J. et al., "Transformation of Mammalion Cells to Antibiotic Resistance with a Bacterial Gene . . . " J. Mol. Appl. Genetics, vol. 1, pp. 327-341, 1982.
Martinez-Arias, A. E. et al., "Fusion of the Saccharomyces Cerevisiae leu 2 Gene to an Escherichia coli B-Galactosidase Gene," mol. Cell. Biology, vol. 3, No. 4, pp. 580-586, 1983.
Colbene-Garapin, F. et al., "A New Dominant Hybrid Selective Marker for Higher Eukaryotic Cells", J. Mol. Biol., 150, pp. 1-14, 1981.
Jimenez, A et al., "Expression of a Transposable Antibiotic Resistance Element in Saccharomyces", Nature, vol. 267, pp. 869-871, 1980.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Selectable fusion protein having aminoglycoside phosphotransfera does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Selectable fusion protein having aminoglycoside phosphotransfera, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selectable fusion protein having aminoglycoside phosphotransfera will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-419129

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.